EverlyWell was founded in 2014 by Julia Cheek. In 2021, parent company Everly Health hired two experienced financial executives, bringing on Chris Bishko as CFO and Kristina Omari as VP of Finance. Omari helped guide Lyft through an IPO in 2019. When asked about an IPO, Cheek told Bizjournals that she was "excited about the future of Everly Health and the opportunity to grow to serve even more Americans — certainly, these appointments positions us to do so." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
EverlyWell describes itself as "a consumer health testing company that connects people with accessible, innovative, and insightful at-home lab tests." In 2021 the company acquired Everly Health Solutions and Home Access Health. EverlyWell has received over $330 million in funding from investors including HealthQuest Capital, Morningside Ventures, Lux Capital, The Chernin Group, and Next Coast Ventures. A recent round of funding brought in $175 million and resulted in a $1.3 billion post-money valuation — a significant increase from the previous year.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/27/2021 | Series F | $154.68MM | $xx.xx | $3.5B | Prysm Capital, Touchdown Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,400,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Prysm Capital, Touchdown Ventures
|
||||||
03/23/2021 | Series E | $192.92MM | $xx.xx | $2.69B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,768,393
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/03/2020 | Series D | $258.1MM | $xx.xx | $1.32B | Blackrock, Foresite Capital, Greenspring Associates, Highland Capital Partners, Morningside Ventures, Portfolio, The Chernin Group | |
Price per Share
$xx.xx
Shares Outstanding
9,879,426
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blackrock, Foresite Capital, Greenspring Associates, Highland Capital Partners, Morningside Ventures, Portfolio, The Chernin Group
|
||||||
02/21/2020 | Series C | $25MM | $xx.xx | $226.76MM | Goodwater Capital, Next Coast Ventures, Nextgen Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,032,450
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Goodwater Capital, Next Coast Ventures, Nextgen Venture Partners
|
||||||
04/16/2019 | Series B | $29.63MM | $xx.xx | $154.74MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,884,140
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/28/2017 | Series A | $9.16MM | $xx.xx | $37.76MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,083,005
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/28/2017 | Series A-1 | $1.46MM | $xx.xx | $37.76MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,523,561
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/19/2016 | Series Seed | $3.14MM | $xx.xx | $8.98MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,174,804
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
Last Funding Round | ||||||||
---|---|---|---|---|---|---|---|---|
Company | Forge Price | Forge Price Change 5 | Last Closed Trade | Share Class | Post-Money Valuation | Price per Share | Amount Raised | |
Cerebras | $40.08 | +0.68% | $xx.xx | Series F-1 | $2.84B | $xx.xx | $85MM | |
CoreWeave | $1,149.84 | +18.78% | $xx.xx | Series C | $19B | $xx.xx | $1.15B | |
Chime | $26.50 | +6.6% | $xx.xx | Series G | $24.93B | $xx.xx | $1.1B | |
Klarna | $370.00 | -1.33% | $xx.xx | Unknown | $6.7B | $xx.xx | -- | |
Liquid Death | $9.49 | +0.21% | $xx.xx | Series F-1 | $1.4B | $xx.xx | $67.61MM | |
Circle | $25.50 | +3.2% | $xx.xx | Series F | $8.05B | $xx.xx | $401MM | |
Netskope | $11.07 | +2.98% | $xx.xx | Series H | $7.5B | $xx.xx | $300MM | |
Cohesity | $15.66 | -2.12% | $xx.xx | Series H-1 | $4.69B | $xx.xx | $27.5MM | |
Turo | $13.00 | +0.31% | $xx.xx | Series E | $1.24B | $xx.xx | $240.52MM | |
Hinge Health | $31.00 | -22.11% | $xx.xx | Series E | $6.2B | $xx.xx | $400MM |
Updated on: Jan 30, 2025
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.
Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.
Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.